HSF Pharmaceuticals S.A. is a Swiss-based, privately owned corporation founded in 2000.
HSF Pharmaceuticals’ core scientific expertise concerns the heat shock or stress response and the regulation of HSF1, the key transcription factor involved in the response. The company intends to exploit various aspects of this physiological response for its products, devices and therapies. It pursues these goals through research collaborations/ partnerships with key individuals and academic institutions as well as by engaging the services of specialized contract research organizations.